Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma

Mantle cell lymphoma (MCL) is a rare and aggressive type of B-cell non-Hodgkin's lymphoma. Patients become progressively refractory to conventional chemotherapy, and their prognosis is poor. However, a 38% remission rate has been recently reported in refractory MCL treated with temsirolimus, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Shi, Wen-Yu, Wu, Zhi-Yuan, Varna, Mariana, Wang, Ai-Hua, Zhou, Li, Chen, Li, Shen, Zhi-Xiang, Lu, He, Zhao, Wei-Li, Janin, Anne
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944815/
https://www.ncbi.nlm.nih.gov/pubmed/20828385
http://dx.doi.org/10.1186/1756-8722-3-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944815/
https://www.ncbi.nlm.nih.gov/pubmed/20828385
http://dx.doi.org/10.1186/1756-8722-3-30

Ejemplares similares